Main Inclusion Criteria:~* Completed 18 months of study treatment and assessments in Baxter precursor study
160701~* Diagnosis of probable AlzheimerÂ´s Disease (AD)~* Able to comply with testing and infusion regimen
(including adequate corrected visual acuity and hearing ability)~* Has a caregiver (study partner) who is
willing and able to participate~Main
